NRF2: A NOVEL BIOMARKER OF DISEASE SEVERITY AND TARGET FOR THERAPEUTIC INTERVENTION IN MULTIPLE SCLEROSIS

$1,413,000FY2012Department of DefenseDOD

Case Western Reserve University, Cleveland OH

Investigators